Cardiac biomarkers are the substances that are released into the bloodstream when the heart is stressed or damaged. Suppression of tumorigenicity 2 (ST2) is one such biomarker used to help in measurement of heart failure risk to assess the treatment options. The ST2 biomarker is a member of the interleukin-1 receptor family biomarker. It is a strong predictor and most promising biomarker for both chronic and acute heart failure.
This report contains market size and forecasts of ST2 Biomarker in Global, including the following market information:
Global ST2 Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global ST2 Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ELISA Based ST2 Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ST2 Biomarker include Thermo Fisher Scientific, BD, Roche, Abbott, Siemens, Bio-Rad and BioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ST2 Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ST2 Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global ST2 Biomarker Market Segment Percentages, by Type, 2021 (%)
ELISA Based ST2 Biomarker
Immunochromatography Based ST2 Biomarker
Global ST2 Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global ST2 Biomarker Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centres
Ambulatory Surgical Centres
Others
Global ST2 Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global ST2 Biomarker Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ST2 Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies ST2 Biomarker revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
BD
Roche
Abbott
Siemens
Bio-Rad
BioMerieux